Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2017 / Article
Special Issue

Harmful and Beneficial Role of ROS 2017

View this Special Issue

Review Article | Open Access

Volume 2017 |Article ID 8765972 | https://doi.org/10.1155/2017/8765972

Arnold N. Onyango, "The Contribution of Singlet Oxygen to Insulin Resistance", Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 8765972, 14 pages, 2017. https://doi.org/10.1155/2017/8765972

The Contribution of Singlet Oxygen to Insulin Resistance

Academic Editor: Victor M. Victor
Received24 Apr 2017
Accepted07 Aug 2017
Published07 Sep 2017


Insulin resistance contributes to the development of diabetes and cardiovascular dysfunctions. Recent studies showed that elevated singlet oxygen-mediated lipid peroxidation precedes and predicts diet-induced insulin resistance (IR), and neutrophils were suggested to be responsible for such singlet oxygen production. This review highlights literature suggesting that insulin-responsive cells such as endothelial cells, hepatocytes, adipocytes, and myocytes also produce singlet oxygen, which contributes to insulin resistance, for example, by generating bioactive aldehydes, inducing endoplasmic reticulum (ER) stress, and modifying mitochondrial DNA. In these cells, nutrient overload leads to the activation of Toll-like receptor 4 and other receptors, leading to the production of both peroxynitrite and hydrogen peroxide, which react to produce singlet oxygen. Cytochrome P450 2E1 and cytochrome c also contribute to singlet oxygen formation in the ER and mitochondria, respectively. Endothelial cell-derived singlet oxygen is suggested to mediate the formation of oxidized low-density lipoprotein which perpetuates IR, partly through neutrophil recruitment to adipose tissue. New singlet oxygen-involving pathways for the formation of IR-inducing bioactive aldehydes such as 4-hydroperoxy-(or hydroxy or oxo)-2-nonenal, malondialdehyde, and cholesterol secosterol A are proposed. Strategies against IR should target the singlet oxygen-producing pathways, singlet oxygen quenching, and singlet oxygen-induced cellular responses.

1. Introduction

Insulin resistance is a condition in which a given concentration of insulin produces a less than expected effect on target cells, and this may lead to impaired glucose tolerance ahead of overt type II diabetes mellitus [1]. It was recently reported that elevated plasma levels of products formed by singlet oxygen-mediated lipid oxidation precede and predicts the development of insulin resistance and diabetes in both humans and mice [2, 3]. Neutrophils recruited to adipose tissue as a result of high-fat feeding were speculated to be responsible for generating the singlet oxygen-modified lipids [2, 3]. On the contrary, the present article highlights literature consistent with (i) a primary role of insulin-responsive cells such as endothelial cells, adipocytes, hepatocytes, and skeletal muscle cells in singlet oxygen formation even prior to the activation of neutrophils and (ii) an important role of singlet oxygen in decreased insulin signaling by the insulin-responsive cells. Key insulin resistance-associated singlet oxygen-producing pathways in these cells are proposed, as well as mechanisms by which this ROS induces insulin resistance. New pathways are proposed for the singlet oxygen-mediated formation of bioactive aldehydes, including cholesterol secosterol aldehyde A, which was previously considered to be exclusively generated by cholesterol ozonolysis and to be a key piece of evidence for endogenous ozone formation.

2. Insulin Signaling

As reviewed by Siddle [4], insulin signaling begins with insulin binding to its receptor, a receptor tyrosine kinase, and this results in the sequential activation of (i) an insulin receptor substrate (IRS), typically IRS-1 or IRS-2, (ii) phosphatidyl inositol 3 kinase (PI3K), (iii) protein kinase B (PKB/Akt), and (iv) various Akt substrates such as the Akt substrate of 160 kDa, whose phosphorylation facilitates translocation of glucose transporter 4 (GLUT 4) from cytoplasmic storage vesicles to the plasma membrane of adipocytes and skeletal muscle cells. Akt-mediated phosphorylation of glycogen synthase kinase 3 results in the activation of glycogen synthase and enhanced glycogen synthesis, while Akt-mediated phosphorylation of the forkhead transcription factor (FOXO 1) prevents translocation of the latter to the nucleus and inhibits expression of enzymes responsible for hepatocyte gluconeogenesis and glycogenolysis [4]. In endothelial cells, Akt phosphorylates and activates endothelial nitric oxide synthase, leading to nitric oxide synthesis [5].

3. Obesity, Adipose-Derived Inflammation, and Insulin Resistance

Chronic adipose tissue inflammation during obesity promotes both adipose tissue and systemic insulin resistance, mainly through the release of proinflammatory compounds by various adipose tissue cells including adipocytes and macrophages, as well as neutrophils that were shown to infiltrate adipose tissue at an early stage of diet-induced obesity in mice [6, 7]. Nevertheless, there is evidence that such adipose tissue-derived inflammation is not essential for the initiation of systemic insulin resistance [8]. In a mouse model of diet-induced obesity, cellular inflammation and insulin resistance occurred first in arterial tissue, within the first week, followed by skeletal muscle and liver between weeks 4 and 8, and these changes were not detected in adipose tissue until week 14 [9]. Likewise, there was absence of systemic inflammation in grade 1 obese women, who displayed IR in skeletal muscle but not in adipose tissue [10]. At the cellular level, cultured endothelial cells, hepatocytes, or skeletal muscle cells treated with palmitate developed insulin resistance in the absence of neutrophils or macrophages [5, 1114]. On the other hand, palmitate does not directly activate neutrophils, and it even reduces hydrogen peroxide production by these cells [15].

4. Toll-Like Receptor 4 or 2 (TLR4 or TLR2) Signaling in Response to High Fat, High Sugar, and Lipopolysaccharide Promotes Insulin Resistance through Oxidative Stress and the Activation of Serine Kinases

Oxidative stress refers to an imbalance between cellular reactive oxygen species (ROS) and antioxidants, in favor of the former [16]. Examples of ROS include superoxide anion (∙−O2), hydrogen peroxide (H2O2), hydroxyl radical (∙OH), singlet oxygen (1O2), and ozone (O3). There is mounting evidence that oxidative stress has a causative role in insulin resistance. For example, attenuating mitochondrial hydrogen peroxide emission by treating rats with a mitochondrial-targeted antioxidant or by overexpressing catalase in mouse skeletal muscle mitochondria preserved insulin sensitivity [17]. Excessive caloric intake by healthy men for 1 week acutely induced weight gain, oxidative stress, and insulin resistance in adipocytes prior to the onset of inflammatory stress [18].

Toll-like receptor 4 (TLR4) signaling is responsible for much of the proinflammatory cytokine production by innate cells [19]. It is also expressed in other cells including endothelial cells, skeletal muscle cells, hepatocytes, and adipocytes, where it contributes to insulin resistance by promoting the formation of ROS and reactive nitrogen species such as nitric oxide (NO), as well as the activation of serine kinases which catalyze serine rather than tyrosine phosphorylation of IRS (Figure 1) [19, 20]. Such serine kinases include protein kinase C (PKC) isoforms, IκB kinase (IKK) complex, and mitogen-activated protein kinases (MAPKs) such as c-Jun N-terminal kinase (JNK) and p38 MAPK [19]. p38 MAPK also activates phosphatase and tensin homolog (PTEN) which reduces phosphorylation of P13K and Akt [11].

Enterobacterial lipopolysaccharide (LPS), whose plasma levels are increased by a high-fat diet, is a direct ligand and activator of TLR4 through its lipid A component which partly consists of palmitic, lauric, or myristic acids [19, 20]. On the other hand, fatty acids and sugars may interact indirectly with TLR via diacylglycerol (DAG) synthesis and subsequent PKC and NADPH oxidase (Nox) activation (Figure 1), as discussed shortly. TLR signaling requires adaptors such as myeloid differentiation primary response protein 88 (myD88) and TIR-domain-containing adapter-inducing interferon-β (TRIF) [19, 21]. Both TLR2 and TLR4 signal via the myD88 pathway whereby myD88 leads to activation of TAK 1, a member of the MAPK kinase family, which activates both the IKK complex-nuclear factor kappa B (NF-kB) pathway and MAPKs such as ERK1/2, JNK, and p38 [21]. IKK activation leads to phosphorylation of the NF-kB inhibitor, IkBα, whose subsequent proteosomal degradation frees NF-kB to translocate to the nucleus and activate the expression of proinflammatory cytokines as well as inducible nitric oxide synthase (iNOS) and Nox components such as p91phox and p22phox [1922].

An increase in intracellular diacylglycerol (DAG) was suggested as a unifying hypothesis that could explain most forms of insulin resistance [8]. During hyperglycemia, de novo DAG synthesis occurs via the polyol pathway [23]. During fatty acid overload, DAGs are synthesized as intermediates in triacylglycerol synthesis [24]. DAG is an essential cofactor and activator of PKC isoforms such as PKC-α, PKC-δ, PKC-ε, PKC-ζ, and PKC-θ which catalyze serine phosphorylation of IRS-1 [25]. These PKC isoforms also interact with TLR and other components of the TLR4 pathway such as myD88 to promote NF-kB activation [26]. PKCs also activate Nox by promoting p47phox translocation to the membrane [27]. Nox isoforms such as Nox2, Nox3, and Nox4 have a critical role in hepatocyte, endothelial cell, skeletal muscle cell, and adipocyte insulin resistance [11, 12, 2830], and Nox-derived ROS contribute to TLR4 activation and signaling [31].

iNOS plays a key role in skeletal muscle, adipose tissue, and hepatic insulin resistance [3234]. Nox-derived superoxide anion (∙−O2) and iNOS-derived nitric oxide (NO) undergo a diffusion-controlled reaction to form the peroxynitrite anion (ONOO−) (Figure 1), and this is the only reaction that occurs at comparable or even higher rate than superoxide dismutase- (SOD-) catalyzed conversion of superoxide anion to hydrogen peroxide [35]. Peroxynitrite is a major contributor to insulin resistance. For example, treatment of cultured adipocytes with hypochlorous acid (HOCl) resulted in adipocyte peroxynitrite production, PKC-θ, IKK, JNK phosphorylation, IRS-1 serine 307 phosphorylation, and insulin resistance, and peroxynitrite inhibitors abolished the rest of these events [36]. The biological effects of peroxynitrite have largely been attributed to its direct oxidation of thiol groups, or its involvement in the formation of radicals that participate in reactions such as lipid oxidation and protein tyrosine nitration [33, 35]. However, the mechanism by which peroxynitrite induces PKC-θ, IKK, JNK, and IRS-1 serine 307 phosphorylation may at least partly involve singlet oxygen-mediated ER stress because (i) peroxynitrite is involved in singlet oxygen formation (Sections 7 and 8), (ii) singlet oxygen induces ER stress (Section 10), and (iii) ER stress activates PKC-θ, IKK, and JNK [34, 37, 38].

5. The Receptor for Advanced Glycation End Products (RAGE) Mediates Similar Effects as TLR4

Serum advanced glycation end products (AGEs) are an independent determinant of insulin resistance as determined by the homeostatic model assessment method (HOMA-IR) in both males and females [39]. AGEs signal via the RAGE receptor, which, like TLR4, induces the recruitment of myD88 and TIRAP, and downstream signaling via NF-kB upon phosphorylation of the cytoplasmic domain of RAGE by PKC-ζ [40]. RAGE signaling is associated with a positive autoregulatory loop that perpetuates NF-kB activation, since NF-kB increases the expression of RAGE [41] and the RAGE-ligand, high mobility box protein [42]. Thus, AGE-RAGE signaling is a key player in endothelial cell dysfunction and adipocyte insulin resistance [40, 41]. Apart from AGEs, a high concentration of uric acid also induces endothelial dysfunction through the RAGE receptor [42].

6. Elevated Singlet Oxygen Production Precedes Insulin Resistance and Diabetes

According to recent reports, plasma levels of two hydroxy-octadecadienes (HODES) specifically derived from singlet oxygen-mediated linoleic acid (LA) oxidation, namely, 10-hydroxy-8(E), 12(Z)-octadecadienoic acid and 12-hydroxy-9(Z),13(E)-octadecadienoic acid, rather than two HODES specifically derived from free radical LA oxidation, namely, 13-hydroxy-9(E),11(E)-octadecadienoic acid and 9-hydroxy-10(E),12(E)-octadecadienoic acid, are suitable biomarkers for predicting insulin resistance and type 2 diabetes in humans [2, 43]. Further, Tsumura Suzuki obese diabetes (TSOD) mice on a high-fat diet had significantly higher singlet oxygen-associated fatty acid oxidation products than control mice at week 5, ahead of significant differences in free radical oxidation-derived products and insulin resistance at week 8 [3]. Thus, it was suggested that excessive singlet-oxygen formation occurs as an early event in the pathogenesis of insulin resistance and type 2 diabetes and that singlet oxygen may be directly or indirectly involved in initiating these disorders [3].

7. Diverse Cell Types, Including Insulin-Responsive Cells, Produce Singlet Oxygen

Murotomi et al. [3] suggested that activated neutrophils were responsible for the elevated plasma levels of singlet oxygen-associated LPO products in TSOD mice, through the myeloperoxidase-HOCl-H2O2 system. However, as recently reviewed, singlet oxygen can be generated through many types of reactions involving molecules that are found in virtually all cell types [44], which is not consistent with this ROS being produced just by leukocytes. Interestingly, singlet oxygen is now recognized as an important signaling molecule in plant cells, as a result not only of its photodynamic formation in chloroplasts but also by dark reactions in nonphotosynthetic cells, even in roots, in response to wounding and other stresses [45]. Peroxisomes, mitochondria, and the nucleus are major intracellular regions of such plant cell singlet oxygen formation in the dark [45]. Although the mechanism of formation of singlet oxygen under such conditions is unknown, this may at least partly involve the reaction of peroxynitrite and hydrogen peroxide, because this reaction produces singlet oxygen [46] and peroxisomes are a site for both hydrogen peroxide and peroxynitrite formation in plant cells [47]. Singlet oxygen was also reported to be generated not only by cultured tumor cells but also by the cell-free culture medium upon the addition of hydrogen peroxide, by a process involving the formation of excited carbonyls [48]. Singlet oxygen formation has been demonstrated in enterocytes [49], endothelial cells [50], and hepatocytes [49, 51]. During liver ischemia-reperfusion injury, acute hepatocyte oxidative stress can occur independently of Kupffer cells, the resident macrophages [52], and hepatocyte oxidative stress produces cytokines and chemokines that activate the latter [53], which is a major source of singlet oxygen prior to neutrophil activation [54]. Such a sequence of hepatocyte-Kupffer cell-neutrophil oxidative stress and singlet oxygen formation might occur during nutrient overload and the development of hepatic insulin resistance. Cytochrome P450 2E1, whose protein levels are 10 times higher in hepatocytes than in Kupffer cells [55] and whose expression is induced by xenobiotics as well lipid overload [55, 56], is an important contributor to singlet oxygen formation by liver microsomes [57].

8. The Importance of Peroxynitrite Anion in Singlet Oxygen Formation during the Pathogenesis of Insulin Resistance

The reaction between peroxynitrite and hydrogen peroxide may produce more singlet oxygen than the neutrophil-associated reaction between hypochlorous acid and hydrogen peroxide in vivo because hypochlorous acid is very reactive with other biomolecules [58]. The related reaction between nitric oxide and hydrogen peroxide was also found to release large amounts of chemiluminescence due to singlet oxygen, and this reaction was suggested to be involved in nitric oxide-mediated cell killing [59]. Since insulin-responsive cells upregulate Nox and iNOS expression and the resultant formation of nitric oxide, peroxynitrite, and hydrogen peroxide under conditions relevant to insulin resistance (Sections 4 and 5), singlet oxygen should be generated under such circumstances. Peroxynitrite also reacts with various other molecules to generate singlet oxygen, as recently reviewed [44]. For example, as illustrated in Figure 2, the reaction of peroxynitrite (1) with CO2 forms nitrosoperoxycarbonate (2) which decomposes to reactive carbonate and nitrogen dioxide radicals ((3) and (4), resp.) that readily convert glutathione (5) to glutathyl radical (6) [35, 60]. Glutathyl radicals reacts with oxygen to generate peroxysulphenyl radical (7) which, via tetroxide species (8) and peroxide (9), generates 1O2 and glutathione disulfide (10) [61]. Since glutathione is one of the major peroxynitrite sinks [60], such reactions limit peroxynitrite-dependent free radical reactions while promoting singlet oxygen production.

9. Singlet Oxygen Generated near the Plasma Membrane May Induce Peroxynitrite Formation and Further Singlet Oxygen Formation in Insulin-Responsive Cells via the Death Receptor Fas

When tumor cells are exposed to a low dose of extracellular photodynamically generated singlet oxygen, the latter activates the death receptor Fas, which signals to upregulate Nox and NOS, resulting in peroxynitrite and H2O2 formation, and a “massive increase in secondary singlet oxygen” [62]. A similar phenomenon may contribute to endothelial cell dysfunction, because (i) endothelial cells express the Fas receptor [63]; (ii) endothelial cells may generate extracellular singlet oxygen because hydrogen peroxide and peroxynitrite formed in them can cross the plasma membrane [35]; (iii) treatment of endothelial cells with 3-morpholinosydnonimine (SIN-1), a peroxynitrite donor, increased iNOS expression via NF-kB and thus established a positive feedback loop for peroxynitrite formation [64]; (iv) high glucose-induced, Nox-mediated endothelial cell dysfunction is exacerbated by myeloperoxidase, which utilizes endothelial cell-derived hydrogen peroxide to generate hypochlorous acid [65], and should thus produce extracellular singlet oxygen by the reaction of the latter with hydrogen peroxide; and (v) apart from a direct effect of singlet oxygen on the endothelial cell Fas receptor, singlet oxygen may oxidize LDL to produce oxidized LDL, which signals via the Fas receptor to induce endothelial cell apoptosis accompanied by activation of MAP and Jun kinases [63]. In fact, the already mentioned (Section 4) hypochlorous acid-mediated, peroxynitrite-dependent induction of insulin resistance in cultured adipocytes [36] may involve a similar mechanism, whereby adipocyte-derived H2O2 reacts with HOCl to generate singlet oxygen, which then activates Fas. The latter, which has been shown to induce adipocyte insulin resistance [66], will then induce iNOS and Nox. The induction of iNOS activity in response to Fas activation in hepatocytes was shown to be a mechanism to reduce apoptosis and enhance survival [67]. Although the foregoing examples assume the activation of Fas by extracellular singlet oxygen, the same effects might generally result from singlet oxygen generated on either side of the plasma membrane, since singlet oxygen photodynamically generated near the plasma membrane was found to induce endothelial cell apoptosis [68]. In hepatocytes, Fas activation also promotes CYP2E1 activity [69], which is an important source of singlet oxygen [57].

10. Singlet Oxygen Formation in the Endoplasmic Reticulum Induces ER Stress

Endoplasmic reticulum stress is an important contributor to adipose tissue and hepatic insulin resistance, through multiple mechanisms including (i) activating JNK and p38, (ii) inducing the pseudokinase tribble 3 (TRB3), which prevents insulin-induced Akt phosphorylation, and (iii) upregulating protein tyrosine phosphatase B (PTPB), a negative regulator of the insulin receptor [34, 70, 71]. The ER stress-inhibiting chaperone tauroursodeoxycholic acid (TUDCA) has been shown to improve insulin signaling in both mice and humans [72, 73].

Singlet oxygen photodynamically generated within the ER induces calcium efflux and ER stress [74]. Cytochrome P450 2E1 (CYP2E1), which is mainly located in the ER, is a strong producer of superoxide [56] and also produces peroxynitrite even in the absence of iNOS [75]. Since the ER constantly produces H2O2 during protein folding [76], the reaction of CYP2E1-derived peroxynitrite with H2O2 to generate singlet oxygen and thereby induce ER stress is highly likely. CYP2E1 also generates singlet oxygen by a mechanism independent of peroxynitrite [57]. This protein also promotes lipid peroxidation, and its expression correlates with lipid peroxidation in obese patients [56, 77]. CYP2E1 expression is induced by JNK [78], which may be activated by pathways such as TLR4 or Fas [Sections 4 and 9], and CYP2E1 in turn strongly activates JNK [78]. Interestingly, adipocytes and hepatocytes strongly express CYP2E1 [78] and are prone to ER stress [34], while skeletal muscle cells only weakly express this protein [79, 80] and are less prone to ER stress [34]. There are both iNOS-dependent and iNOS-independent pathways for ER stress in the adipose tissue and liver, and silencing iNOS and abolishing the residual ER stress completely abolishes insulin resistance in these organs [34]. The iNOS-independent ER stress can be well explained by CYP2EI in hepatocytes and adipocytes. Whole body CYP2E1 knockout protected mice from HFD-induced obesity and insulin resistance, and it especially improved insulin sensitivity in hepatic and adipose tissues but not skeletal muscle tissue [81].

11. Mitochondrial Singlet Oxygen Formation Damages Mitochondrial DNA

Mitochondria are a key site for peroxynitrite formation due to NO easily diffusing into them and reacting with superoxide formed as a result of electron leakage from the electron transport chain [35]. Peroxynitrite further promotes such electron leakage, resulting in the elevation of mitochondrial H2O2 [35, 82], thus setting the right conditions for singlet oxygen formation by these two reactive species. Hence, mitochondria should be a major site for peroxynitrite-dependent singlet oxygen formation. This is consistent with the findings that, in skeletal muscle cells, mitochondrial ROS and the resultant DNA damage and apoptosis contribute to insulin resistance [13], attenuating mitochondrial hydrogen peroxide emission prevents skeletal muscle insulin resistance [17], deletion of iNOS or addition of a peroxynitrite inhibitor prevents such mitochondrial DNA damage and insulin resistance [14, 34], and skeletal muscles from rats injected with LPS produced singlet oxygen, which was associated with increased Nox and iNOS activity, hydrogen peroxide and peroxynitrite formation, and enhanced mitochondrial lipid oxidation [83].

ER calcium efflux is another major contributor to mitochondrial ROS, since it causes mitochondrial calcium influx, which greatly enhances mitochondrial superoxide production, for example, in cardiomyocytes [76]. In hepatocytes, uric acid-induced activation of Nox preceded ER stress, which further induced mitochondrial ROS [84].

Increased mitochondrial H2O2 either as a result of peroxynitrite production or calcium influx may promote singlet oxygen formation by an additional pathway involving cardiolipin oxidation. In the presence of H2O2, cytochrome c acts as a cardiolipin-specific oxygenase, converting cardiolipin (11) to a cardiolipin hydroperoxide such as (12) (Figure 3) [85]. The decomposition of cardiolipin hydroperoxide generates triplet carbonyls that transfer energy to triplet oxygen and thus form singlet oxygen [86]. Formation of such triplet carbonyls from cardiolipin hydroperoxide (12) may partly involve the amine- (RNH2-) catalyzed conversion of the latter to dioxetane (13), whose decomposition affords an aldehydic cardiolipin (14) and 3(Z)-nonenal (15), either of which could be in the excited triplet state (Figure 3). The amine (RNH2) could be a lysine residue or the amino group of phosphatidylethanolamine or phosphatidylserine. Such amine-catalyzed conversion of the 13-hydroperoxide of linoleic acid (13-hydroperoxy-9Z, 11E-octadecadienoic acid, HPODE) to a dioxetane that yields hexanal was recently suggested [44] to explain the known reaction of lysine with HPODE to form Nε-(hexanoyl)lysine (HEL), which does not form by reaction of preformed hexanal with lysine in the absence of HPODE [87]. The Schiff base between hexanal and lysine was suggested to react with a second HPODE molecule to form HEL [44]. Formyl-lysine, a product analogous to HEL, is formed in a system containing formaldehyde, lysine, and H2O2 [88], where H2O2 (rather than a lipid hydroperoxide) reacts with the corresponding Schiff base. The fact that plasma HEL levels were significantly and positively correlated with fasting plasma glucose, serum insulin, and HOMA-IR in obese males [89] indicates that this kind of reaction is important in vivo.

Amines also catalyze a reaction between hydrogen peroxide and carbonyls (including sugars) to form singlet oxygen and excited carbonyls [44, 88, 90]. Such reactions might be responsible for the already-mentioned formation of singlet oxygen upon addition of hydrogen peroxide to a cell-free culture medium (Section 7) [48]. Accordingly, aldehyde (16), the nonexcited form of (14), may react with H2O2 to form singlet oxygen and to regenerate (14), thus amplifying singlet oxygen formation. In this way, any other aldehydes formed in the mitochondrion may participate in singlet oxygen formation. This aldehyde-amine-hydrogen peroxide-dependent mechanism of singlet oxygen formation may be equally important in the ER since it has been demonstrated in liver microsomes [88, 90], where CYP2E1 induces lipid oxidation in an environment favoring H2O2 formation [77].

12. Singlet Oxygen Oxidizes Low-Density Lipoprotein

Oxidized low-density lipoproteins (oxLDLs) were positively associated with HOMA-IR in young human adults independently of obesity in a longitudinal study [91]. Similar strong association between oxLDL levels and insulin resistance was obtained in a weight reduction study [92]. Endothelial cells mediate oxLDL formation by a peroxynitrite-dependent mechanism [93], indicating the potential involvement of singlet oxygen, since both singlet oxygen and oxLDL are strong precursors of insulin resistance [3, 92]. oxLDL can perpetuate the effects of HFD on endothelial cells, because its signaling via the lectin-like oxidized low-density lipoprotein receptor-1 (Lox-1 receptor) and TLR4 receptors initiates a positive autoregulatory loop for NF-kB activation and upregulation of Lox-1 receptor expression [94]. This also induces the expression of vascular cell adhesion molecule 1 (VCAM 1) and monocyte chemoattractant protein (MCP-1), which promote the recruitment of immune cells [94]. OxLDL signaling in adipocytes induces adipocyte insulin resistance through the activation of IKK, JNK, and NF-kB, even independently of further ROS formation [95], and this may involve the interaction of oxLDL receptor with CD36, resulting in CD36 association with the Src family tyrosine kinases Fyn and Lyn upstream of JNK [96]. oxLDL also reduces adiponectin secretion [97], and this affects systemic insulin resistance because adiponectin improves insulin sensitivity in endothelial cells, hepatocytes, and skeletal muscle cells [98].

As already discussed (Section 3), palmitate induces insulin resistance in insulin-responsive cells independently of neutrophils, but the latter are recruited to adipose tissue and promote diet-induced insulin resistance by producing myeloperoxidase and other proinflammatory substances. While palmitate lowers ROS formation by neutrophils [15], oxLDL induces neutrophil transmigration across microvascular endothelial cell monolayers and their subsequent degranulation especially after endothelial cell activation [99]. Extracellular hydrogen peroxide mediates the paracrine recruitment of neutrophils to wounded tissue [100]. Therefore, H2O2 produced by adipocytes, together with endothelial cell-derived oxLDL, may contribute to neutrophil infiltration and activation in adipose tissue.

13. Singlet Oxygen Increases Intracellular Ceramide Levels

Ceramide is a key contributor to insulin resistance by several mechanisms including, but not limited to, (i) activation of protein phosphatase 2A (PP2A) which dephosphorylates Akt, (ii) activation of the atypical PKC isoform ζ which inhibits Akt, and (iii) JNK activation [101].

Singlet oxygen induces the nonenzymatic conversion of sphingomyelin to ceramide in tumor cells, and there is an autocrine loop linking such ceramide increase to de novo ceramide biosynthesis [102]. There is a possibility that, at least the nonenzymatic mechanism, may be involved in ceramide formation in insulin-responsive cells such as skeletal muscle cells and adipocytes. Singlet oxygen may also contribute indirectly to ceramide accumulation via oxLDL-mediated decrease in adiponectin, since the latter has ceramidase activity [101], or by oxLDL-mediated sphingomyelinase activation [103]. Besides, ER stress and ceramide accumulation induce each other in a vicious cycle [101].

14. Singlet Oxygen Contributes to the Formation of Insulin Resistance-Promoting Reactive Carbonyl Species

The decomposition of lipid hydroperoxides affords highly reactive aldehydic products such as malondialdehyde (MDA), glyoxal, acrolein, 4-hydroperoxy-2-nonenal (HPNE), 4-hydroxy-2-nonenal (HNE), and 4-oxo-2-nonenal (ONE), which contribute to insulin resistance in various ways. Plasma MDA concentration positively correlates with insulin resistance [104]. ONE induces primary hepatocyte apoptosis through increased xanthine oxidase (XO) activity [105]. By promoting XO activity, ONE potentially contributes to the formation of uric acid, which induces endothelial dysfunction as well as hepatocyte ER stress [42, 84]. ONE reacts with lysine to form Nε-(4-oxononanoyl)lysine, an important ligand of Lox-1 receptor [106] and may thus make a major contribution to oxLDL-mediated insulin resistance. Protein-HNE adducts but not protein carbonyl levels were found to be related to intramyocellular lipid content and the severity of insulin resistance in humans [107].

Various mechanisms for the formation of some of the above-named aldehydes during free radical lipid oxidation have been proposed [108110]. However, such purely free radical mechanisms do not adequately explain the generation of some lipid oxidation products in vivo. Notably, according to the free radical-dependent reactions, linoleic acid is not expected to be an important precursor of MDA [109], while, on the contrary, plasma linoleic acid was found to be an important precursor of this aldehyde [111]. Furthermore, the reaction of lysine with HPNE, a derivative of linoleic acid, was found to generate MDA by an unknown mechanism [112].

HPNE (17) may be formed by the reaction of 3(Z)-nonenal (15) with singlet oxygen (Figure 3). Similarly to the conversion of hydroperoxide (12) to dioxetane (13) (Figure 3), HPNE (17) may be converted by an amine (RNH2) via dioxetane (18) to MDA (19) and hexanal (20) (Figure 4), thus explaining the previously reported, lysine-mediated conversion of HPNE to MDA [112]. Inorganic ferrous ion (Fe2+) or organic ferric ions such as in cytochrome c (Cy-Fe3+) may alternatively convert HPNE (17) to the corresponding alkoxyl radical (21), which can abstract or lose a hydrogen to form HNE (22) or ONE (23), respectively, or cyclize to form epoxyalkyl radical (24), which rearranges to oxygen-stabilized vinyl ether radical (25) [113, 114]. The latter may react with oxygen and be converted via hydroperoxy-ether (26) and oxygen-centered radical (27) to hemiacetal (28). Vinyl ether radicals such as (25) also undergo direct conversion to hemiacetals such as (28) by oxygen rebound from the Cy-Fe4+ −OH (or Fe3+ −OH) pair, and the hemiacetals easily cleave to aldehydes such as MDA (19) and hexanal (20) [113114].

Cholesterol oxidation generates two main aldehydic products, namely, cholesterol secosterol A and secosterol B [115]. Secosterol A potently inhibits endothelial nitric oxide synthase (eNOS) and neuronal nitric oxide synthase (nNOS), but not iNOS [116], and should therefore make an important contribution to endothelial dysfunction and insulin resistance, since eNOS promotes insulin sensitivity while iNOS promotes insulin resistance in humans [117].

Singlet oxygen but not free radical oxidation readily converts cholesterol to cholesterol-5-hydroperoxide (29), which, under acidic conditions, undergoes Hock cleavage to form cholesterol secosterol aldehyde A (30), followed by rapid acid-catalyzed aldolization of the latter to form secosterol B (31) (Figure 5), so that secosterol A is only detected as a minor product under such conditions [115, 118]. On the other hand, ozonolysis of cholesterol affords secosterol A as the main product [115, 118, 119]. Both secosterol aldehydes A and B have been isolated in significant quantities from various human tissues and LDL, confirming the importance of singlet oxygen, ozone, and/or an ozone-like oxidant in in vivo lipid oxidation [115, 118, 119]. These aldehydes were also detected in the plasma and other tissues of normal mice, further supporting the formation of singlet oxygen in endothelial cells and other cell types independently of leukocyte activation and inflammation [120]. The fact that secosterol A is a major product in vivo was interpreted as evidence for endogenous ozone formation [115, 118, 119]. Potential mechanisms for the antibody- or amino acid-catalyzed endogenous ozone formation in the presence of singlet oxygen have been proposed [119, 121]. However, Tomono et al. [122] reported that almost equal amounts of secosterols A and -B were formed in vitro from cholesterol oxidation by human myeloperoxidase (MPO) independently of antibody involvement and concluded that, in this case, singlet oxygen and possibly another oxidant, but not ozone, mediated the formation of both secosterols A and B.

As suggested in Figure 5, the amine-catalyzed decomposition of cholesterol 5-hydroperoxide (29) affords dioxetane (32) whose decomposition generates secosterol A (30) under nonacidic conditions. Moreover, cytochrome c-mediated conversion of cholesterol 5-hydroperoxide (29) to the corresponding alkoxyl radical and epoxyalkyl radicals was recently reported [123]. The said epoxyalkyl radical (not shown) may be converted to secosterol A (30) analogously to the conversion of epoxylakyl radical (24) to aldehydes (19) and (20) in Figure 4. It would not be unreasonable to postulate that hydroperoxyvinyl ether (33) (formed analogously to (26) in Figure 4) may undergo amine-catalyzed conversion to secondary ozonide (34), analogously to the amine-catalyzed formation of dioxetanes such as (32). Hydrolysis of secondary ozonide (34) then affords secosterol A (30) [124]. Thus, a combination of singlet oxygen, a metal ion, triplet oxygen, and an amine might act as an ozone-like oxidant.

15. Conclusion

Insulin resistance is a major precursor of diabetes and cardiovascular diseases, whose etiological pathways deserve attention. This review has highlighted the pathways of formation of singlet oxygen in insulin-responsive cells and how this ROS contributes to insulin resistance through ER stress, mitochondrial DNA damage, and the formation of oxLDL and bioactive aldehydes such as MDA, HNE, ONE, and cholesterol secosterol aldehydes A and B. Strategies for the prevention or management of insulin resistance may need to include dietary singlet oxygen quenching antioxidants but only as part of a multipronged approach that also targets events both upstream and downstream of singlet oxygen formation, such as inhibiting TLR4 signaling, detoxification of bioactive aldehydes, and inhibiting ER stress. Nevertheless, there is a need for more studies to directly determine the relative contribution of singlet oxygen to insulin resistance vis a vis other reactive oxygen and nitrogen species.

Conflicts of Interest

The author declares that there is no conflict of interests regarding the publication of this paper.


  1. M. H. Shanik, Y. Xu, J. Skrh, R. Dankner, Y. Zick, and J. Roth, “Insulin resistance and hyperinsulinemia,” Diabetes Care, vol. 31, pp. S262–S268, 2008. View at: Publisher Site | Google Scholar
  2. A. Umeno, M. Shichiri, N. Ishida et al., “Singlet oxygen induced products of linoleates, 10- and 12-(Z, E)-hydroxy-octadecadienoic acids (HODE), can be potential biomarkers for early detection of type 2 diabetes,” PLoS One, vol. 8, article e63542, 2013. View at: Publisher Site | Google Scholar
  3. K. Murotomi, A. Umeno, M. Yasunaga et al., “Switching from singlet-oxygen-mediated oxidation to free-radical-mediated oxidation in the pathogenesis of type 2 diabetes in model mouse,” Free Radical Research, vol. 49, pp. 133–138, 2015. View at: Publisher Site | Google Scholar
  4. K. Siddle, “Signaling by insulin and IGF receptors: supporting acts and new players,” Journal of Molecular Endocrinology, vol. 47, pp. R1–R10, 2011. View at: Publisher Site | Google Scholar
  5. Q. Wang, X.-L. Cheng, D.-Y. Zhang, X.-J. Gao, and L. Zhou, “Tectorigenin attenuates palmitate-induced endothelial insulin resistance via targeting ROS-associated inflammation and IRS-1 pathway,” PLoS One, vol. 8, article e66417, 2013. View at: Publisher Site | Google Scholar
  6. H. Kwon and J. E. Pessin, “Adipokines mediate inflammation and insulin resistance,” Frontiers in Endocrinology (Lausanne), vol. 4, p. 71, 2013. View at: Publisher Site | Google Scholar
  7. S. Talukdar, D. Y. Oh, G. Bandyopadhyay et al., “Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase,” Nature Medicine, vol. 18, pp. 1407–1412, 2012. View at: Publisher Site | Google Scholar
  8. D. M. Erion and G. I. Shulman, “Diacylglycerol-mediated insulin resistance,” Nature Medicine, vol. 16, pp. 400–402, 2010. View at: Publisher Site | Google Scholar
  9. F. Kim, M. Pham, E. Maloney et al., “Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance,” Arteriosclerosis, Thrombosis and Vascular Biology, vol. 28, pp. 1982–1988, 2008. View at: Publisher Site | Google Scholar
  10. C. Amouzou, C. Breuker, O. Fabre et al., “Skeletal muscle insulin resistance and absence of inflammation characterize insulin resistant grade I obese women,” PLoS One, vol. 11, article e0154119, 2016. View at: Publisher Site | Google Scholar
  11. D. Gao, S. Nong, X. Huang et al., “The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways,” Journal of Biological Chemistry, vol. 285, no. 39, pp. 29965–29973, 2010. View at: Publisher Site | Google Scholar
  12. S. P. de Figueiredo, A. B. Salmon, F. Bruno et al., “Nox2 mediates skeletal muscle insulin resistance induced by a high fat diet,” Journal of Biological Chemistry, vol. 290, pp. 13427–13439, 2015. View at: Publisher Site | Google Scholar
  13. L. Yuzefovych, G. Wilson, and L. Rachek, “Different effects of oleate vs. palmitate on mitochondrial function, apoptosis, and insulin signaling in L6 skeletal muscle cells: role of oxidative stress,” American Journal of Physiology - Endocrinology and Metabolism, vol. 299, pp. E1096–E1105, 2010. View at: Publisher Site | Google Scholar
  14. L. Rachek, S. Musiyenko, S. P. LeDoux, and G. L. Wilson, “Palmitate induced mitochondrial deoxyribonucleic acid damage and apoptosis in l6 rat skeletal muscle cells,” Endocrinology, vol. 148, pp. 293–299, 2007. View at: Publisher Site | Google Scholar
  15. H. Akamatsu, Y. Niwa, and K. Matsunaga, “Effect of palmitic acid on neutrophil functions in vitro,” International Journal of Dermatology, vol. 40, pp. 640–643, 2001. View at: Publisher Site | Google Scholar
  16. J. Lugrin, N. Rosenblatt-Velin, R. Parapanov, and L. Liaudet, “The role of oxidative stress during inflammatory processes,” Biological Chemistry, vol. 395, pp. 203–230, 2014. View at: Publisher Site | Google Scholar
  17. E. J. Anderson, M. E. Lustig, K. E. Boyle et al., “Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans,” The Journal of Clinical Investigation, vol. 119, pp. 573–581, 2009. View at: Publisher Site | Google Scholar
  18. G. Boden, C. Homko, C. A. Barrero et al., “Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men,” Science Translational Medicine, vol. 7, article 304re7, 2015. View at: Publisher Site | Google Scholar
  19. J. J. Kim and D. D. Sears, “TLR4 and insulin resistance,” Gastroenterology Research and Practice, vol. 2010, Article ID 212563, 11 pages, 2010. View at: Publisher Site | Google Scholar
  20. L. A. Velloso, F. Folli, and M. J. Saad, “TLR4 at the crossroads of nutrients, gut microbiota, and metabolic inflammation,” Endocrine Reviews, vol. 36, pp. 245–271, 2015. View at: Publisher Site | Google Scholar
  21. T. Kawasaki and T. Kawai, “Toll-like receptor signaling pathways,” Frontiers in Immunology, vol. 5, p. 461, 2014. View at: Publisher Site | Google Scholar
  22. M. J. Morgan and Z. Liu, “Crosstalk of reactive oxygen species and NF-κB signaling,” Cell Research, vol. 21, pp. 103–115, 2011. View at: Publisher Site | Google Scholar
  23. W. H. Tang, K. A. Martin, and J. Hwa, “Aldose reductase, oxidative stress, and diabetic mellitus,” Frontiers in Pharmacology, vol. 3, p. 87, 2012. View at: Publisher Site | Google Scholar
  24. L. Liu, X. Shi, C. S. Choi et al., “Paradoxical coupling of triglyceride synthesis and fatty acid oxidation in skeletal muscle overexpressing DGAT1,” Diabetes, vol. 58, pp. 2516–2524, 2009. View at: Publisher Site | Google Scholar
  25. S. Turban and E. Hajduch, “Protein kinase C isoforms: mediators of reactive lipid metabolites in the development of insulin resistance,” FEBS Letters, vol. 585, pp. 269–274, 2011. View at: Publisher Site | Google Scholar
  26. D. J. Loegering and M. R. Lennartz, “Protein kinase C and toll-like receptor signaling,” Enzyme Research, vol. 2011, Article ID 537821, 7 pages, 2011. View at: Publisher Site | Google Scholar
  27. D. Cosentino-Gomes, N. Rocco-Machado, and J. Roberto Meyer-Fernandes, “Cell signaling through protein kinase C oxidation and activation,” International Journal of Molecular Sciences, vol. 13, pp. 10697–10721, 2012. View at: Publisher Site | Google Scholar
  28. S. Pereira, E. Park, Y. Mori et al., “FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress,” American Journal of Physiology - Endocrinology and Metabolism, vol. 307, pp. E34–E46, 2014. View at: Publisher Site | Google Scholar
  29. P. Sukumar, H. Viswambharan, H. Imrie et al., “Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction,” Diabetes, vol. 62, no. 6, pp. 2130–2134, 2013. View at: Publisher Site | Google Scholar
  30. L. J. D. Hartigh, M. Omer, L. Goodspeed et al., “Adipocyte-specific deficiency of NADPH oxidase 4 delays the onset of insulin resistance and attenuates adipose tissue inflammation in obesity,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 37, no. 3, pp. 466–475, 2017. View at: Publisher Site | Google Scholar
  31. S. W. Wong, M. J. Kwon, A. M. Choi, H. P. Kim, K. Nakahira, and D. H. Hwang, “Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner,” Journal of Biological Chemistry, vol. 284, pp. 27384–27392, 2009. View at: Publisher Site | Google Scholar
  32. H.-N. Cha, S. E. Song, Y.-W. Kim, J.-Y. Kim, K.-C. Won, and S.-Y. Park, “Lack of inducible nitric oxide synthase prevents lipid-induced skeletal muscle insulin resistance without attenuating cytokine level,” Journal of Pharmacological Sciences, vol. 117, pp. 77–86, 2011. View at: Publisher Site | Google Scholar
  33. A. Charbonneau and A. Marette, “Inducible nitric oxide synthase induction underlies lipid-induced hepatic insulin resistance in mice,” Diabetes, vol. 59, pp. 861–871, 2010. View at: Publisher Site | Google Scholar
  34. T. M. Zanotto, P. G. F. Quaresma, D. Guadagnini et al., “Blocking iNOS and endoplasmic reticulum stress synergistically improves insulin resistance in mice,” Molecular Metabolism, vol. 6, pp. 206–218, 2017. View at: Publisher Site | Google Scholar
  35. R. Radi, “Protein tyrosine nitration: biochemical mechanisms and structural basis of its functional effects,” Accounts of Chemical Research, vol. 46, pp. 550–559, 2013. View at: Publisher Site | Google Scholar
  36. J. Zhou, Q. Wang, Y. Ding, and M. H. Zou, “Hypochlorous acid via peroxynitrite activates protein kinase Cθ and insulin resistance in adipocytes,” Journal of Molecular Endocrinology, vol. 54, pp. 25–37, 2015. View at: Publisher Site | Google Scholar
  37. K. Sakaki and R. J. Kaufman, “Regulation of ER stress-induced macroautophagy by protein kinase C,” Autophagy, vol. 4, pp. 841–843, 2008. View at: Google Scholar
  38. Y. Chen, Z. Wu, S. Zhao, and R. Xiang, “Chemical chaperones reduce ER stress and adipose tissue inflammation in high fat diet-induced mouse model of obesity,” Scientific Reports, vol. 6, article 27486, 2016. View at: Publisher Site | Google Scholar
  39. C. B. Tan, S. W. M. Shiu, Y. Wong, and X. Tam, “Serum advanced glycation end products (AGEs) are associated with insulin resistance,” Diabetes/Metabolism Research and Reviews, vol. 27, pp. 488–492, 2011. View at: Publisher Site | Google Scholar
  40. M. Sakaguchi, H. Murata, K. Yamamoto et al., “TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding,” PLoS One, vol. 6, no. 8, article e23132, 2011. View at: Publisher Site | Google Scholar
  41. K. H. J. Gaens, G. H. Goossens, P. M. Niessen et al., “Nε-(carboxymethyl) lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 34, pp. 1199–1208, 2014. View at: Publisher Site | Google Scholar
  42. W. Cai, X.-M. Duan, Y. Liu et al., “Uric acid induces endothelial dysfunction by activating the HMGB1/RAGE signaling pathway,” BioMed Research International, vol. 2017, Article ID 4391920, 11 pages, 2017. View at: Publisher Site | Google Scholar
  43. A. Umeno, K. Yoshino, Y. Hashimoto, M. Shichiri, M. Kataoka, and Y. Yoshida, “Multi-biomarkers for early detection of type 2 diabetes, including10-and 12-(Z,E)-hydroxyoctadecadienoic acids, insulin, leptin, and adiponectin,” PLoS One, vol. 10, article e0130971, 2015. View at: Publisher Site | Google Scholar
  44. A. N. Onyango, “Endogenous generation of singlet oxygen and ozone in human and animal tissues: mechanisms, biological significance, and influence of dietary components,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 2398573, 22 pages, 2016. View at: Publisher Site | Google Scholar
  45. E. Mor, L. Koh, S. Weiner, H. Rosenwasser, H. Sibony-Benyamini, and R. Fluhr, “Singlet oxygen signatures are detected independent of light or chloroplasts in response to multiple stresses,” Plant Physiology, vol. 165, pp. 249–261, 2014. View at: Publisher Site | Google Scholar
  46. P. D. Mascio, E. J. H. Bechara, M. H. G. Medeiros, K. Briviba, and H. Sies, “Singlet molecular oxygen production in the reaction of peroxynitrite with hydrogen peroxide,” FEBS Letters, vol. 355, pp. 287–289, 1994. View at: Google Scholar
  47. F. J. Corpas, J. B. Barroso, J. M. Palma, and M. Rodriguez-Ruiza, “Plant peroxisomes: a nitro-oxidative cocktail,” Redox Biology, vol. 11, pp. 535–542, 2017. View at: Publisher Site | Google Scholar
  48. M. Rác, M. Sedlářová, and P. Pospíšila, “The formation of electronically excited species in the human multiple myeloma cell suspension,” Scientific Reports, vol. 5, p. 8882, 2015. View at: Publisher Site | Google Scholar
  49. E. D. Kerver, I. M. Vogels, K. S. Bosch, H. Vreeling-Sindelárová, R. J. Van den Munckhof, and W. M. Frederiks, “In situ detection of spontaneous superoxide anion and singlet oxygen production by mitochondria in rat liver and small intestine,” Histochemical Journal, vol. 29, pp. 229–237, 1997. View at: Publisher Site | Google Scholar
  50. W. Rosenblum and G. H. Nelson, “Singlet oxygen scavengers affect laser-dye impairment of endothelium-dependent responses of brain arterioles,” American Journal of Physiology, vol. 270, pp. H1258–H1263, 1996. View at: Google Scholar
  51. E. Cadenas, H. Wefers, and H. Sies, “Low-level chemiluminescence of isolated hepatocytes,” European Journal of Biochemistry, vol. 119, pp. 531–536, 1981. View at: Google Scholar
  52. Y. Kumamoto, M. Suematsu, M. Shimazu, and Y. Kato, “Kupffer cell-independent acute hepatocellular oxidative stress and decreased bile formation in post-cold-ischemic rat liver,” Hepatology, vol. 30, pp. 1454–1463, 1999. View at: Publisher Site | Google Scholar
  53. H. S. Younis, A. R. Parrish, and I. G. Sipes, “The role of hepatocellular oxidative stress in Kupffer cell activation during 1,2-dichlorobenzene-induced hepatotoxicity,” Toxicological Sciences, vol. 76, pp. 201–211, 2003. View at: Publisher Site | Google Scholar
  54. J. C. Cutrìn, A. Boveris, B. Zingaro, G. Corvetti, and G. Poli, “In situ determination by surface chemiluminescence of temporal relationships between evolving warm ischemia-reperfusion injury in rat liver and phagocyte activation and recruitment,” Hepatology, vol. 31, pp. 622–632, 2000. View at: Publisher Site | Google Scholar
  55. T. Koivisto, V. M. Mishin, K. M. Mak, P. A. Cohen, and C. S. Lieber, “Induction of cytochrome P-450 2E1 by ethanol in rat Kupffer cells,” Alcoholism: Clinical and Experimental Research, vol. 20, pp. 207–212, 1996. View at: Google Scholar
  56. T.-M. Leung and N. Nieto, “CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 58, pp. 395–398, 2013. View at: Publisher Site | Google Scholar
  57. S. Hayashi, H. Yasui, and H. Sakurai, “Essential role of singlet oxygen in cytochrome P450-dependent substrate oxygenation in rat liver microsomes,” Drug Metabolism and Pharmacokinetics, vol. 20, pp. 14–23, 2005. View at: Publisher Site | Google Scholar
  58. J. K. Hurst, “What really happens in the neutrophil phagosome?” Free Radical Biology and Medicine, vol. 53, pp. 508–520, 2012. View at: Publisher Site | Google Scholar
  59. A. A. Noronha-Dutra, M. E. Epperlein, and N. Woolf, “Reaction of nitric oxide and hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide-mediated killing,” FEBS Letters, vol. 321, pp. 59–62, 1993. View at: Publisher Site | Google Scholar
  60. E. Ford, M. N. Hughes, and P. Wardman, “Kinetics of the reactions of nitrogen dioxide with glutathione, cysteine, and uric acid at physiological pH,” Free Radical Biology and Medicine, vol. 32, pp. 1314–1323, 2002. View at: Publisher Site | Google Scholar
  61. H. Wefers and H. Sies, “Oxidation of glutathione by the superoxide radical to the disulfide and the sulfonate yielding singlet oxygen,” European Journal of Biochemistry, vol. 137, pp. 29–36, 1983. View at: Google Scholar
  62. G. Bauer, “The antitumor effect of singlet oxygen,” Anticancer Research, vol. 36, pp. 5649–5663, 2016. View at: Publisher Site | Google Scholar
  63. C. Napoli, O. Quehenberger, F. de Nigris, P. Abete, C. K. Glass, and W. Palinski, “Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells,” FASEB Journal, vol. 14, pp. 1996–2007, 2000. View at: Publisher Site | Google Scholar
  64. C.-L. M. Cooke and S. T. Davidge, “Peroxynitrite increases iNOS through NF-κB and decreases prostacyclin synthase in endothelial cells,” American Journal of Physiology-Cell Physiology, vol. 282, no. 2, pp. C395–C402, 2002. View at: Publisher Site | Google Scholar
  65. R. Tian, Y. Ding, Y.-Y. Peng, and N. Lu, “Myeloperoxidase amplified high glucose-induced endothelial dysfunction in vasculature: role of NADPH oxidase and hypochlorous acid,” Biochemical and Biophysical Research Communications, vol. 484, pp. 572–578, 2017. View at: Publisher Site | Google Scholar
  66. S. Wueest, R. A. Rapold, E. J. Schoenle, and D. Konrad, “Fas activation in adipocytes impairs insulin-stimulated glucose uptake by reducing Akt,” FEBS Letters, vol. 584, pp. 4187–4192, 2010. View at: Publisher Site | Google Scholar
  67. E. Hatano, B. L. Bennett, A. M. Manning, T. Qian, J. J. Lemasters, and D. A. Brenner, “NF-κB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-α– and Fas-mediated apoptosis,” Gastroenterology, vol. 120, pp. 1251–1262, 2001. View at: Publisher Site | Google Scholar
  68. C. P. Lin, M. C. Lynch, and I. E. Kochevar, “Reactive oxidizing species produced near the plasma membrane induce apoptosis in bovine aorta endothelial cells,” Experimental Cell Research, vol. 259, pp. 351–359, 2000. View at: Publisher Site | Google Scholar
  69. X. Wang, Y. Lu, and A. I. Cederbaum, “Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice,” Hepatology, vol. 42, pp. 400–410, 2005. View at: Publisher Site | Google Scholar
  70. E. Panzhinskiy, J. Ren, and S. Nair, “Protein tyrosine phosphatase 1B and insulin resistance: role of endoplasmic reticulum stress/reactive oxygen species/nuclear factor kappa B axis,” PLoS One, vol. 8, no. 10, article e77228, 2013. View at: Publisher Site | Google Scholar
  71. W. Zhang, V. Hietakangas, S. Wee, S. C. Lim, J. Gunaratne, and S. M. Cohen, “ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylation,” Genes & Development, vol. 27, pp. 441–449, 2013. View at: Publisher Site | Google Scholar
  72. U. Ozcan, E. Yilmaz, L. Ozcan et al., “Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes,” Science, vol. 313, pp. 1137–1140, 2006. View at: Publisher Site | Google Scholar
  73. R.-Q. Sun, H. Wang, X.-Y. Zeng et al., “IRE1 impairs insulin signaling transduction of fructose-fed mice via JNK independent of excess lipid,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1852, pp. 156–165, 2015. View at: Publisher Site | Google Scholar
  74. I. Moserova and J. Kralova, “Role of ER stress response in photodynamic therapy: ROS generated in different subcellular compartments trigger diverse cell death pathways,” PLoS One, vol. 7, no. 3, article e32972, 2012. View at: Publisher Site | Google Scholar
  75. M. A. Abdelmegeed, K.-H. Moon, C. Chen, F. J. Gonzalez, and B.-J. Song, “Role of cytochrome P450 2E1 in protein nitration and ubiquitin-mediated degradation during acetaminophen toxicity,” Biochemistry and Pharmacology, vol. 79, pp. 57–66, 2010. View at: Publisher Site | Google Scholar
  76. R. Chaube and G. H. Werstuck, “Mitochondrial ROS versus ER ROS: which comes first in myocardial dysregulation?” Frontiers in Cardiovascular Medicine, vol. 3, p. 36, 2016. View at: Publisher Site | Google Scholar
  77. I. A. Leclercq, G. C. Farrell, J. Field, D. R. Bell, F. J. Gonzalez, and G. R. Robertson, “CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis,” Journal of Clinical Investigation, vol. 105, pp. 1067–1075, 2000. View at: Publisher Site | Google Scholar
  78. J. M. Schattenberg and M. J. Czaja, “Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling,” Redox Biology, vol. 3, pp. 7–15, 2014. View at: Publisher Site | Google Scholar
  79. D. Molina-Ortiz, J. F. González-Zamora, R. Camacho-Carranza et al., “Xenobiotic-metabolizing enzymes in skeletal muscle of children and adolescents,” Pharmacology and Pharmacy, vol. 4, article 29888, 2013. View at: Google Scholar
  80. C. Smith, S. C. Stamm, J. E. Riggs et al., “Ethanol-mediated CYP1A1/2 induction in rat skeletal muscle tissue,” Experimental and Molecular Pathology, vol. 69, pp. 223–232, 2000. View at: Publisher Site | Google Scholar
  81. H. Zong, M. Armoni, C. Harel, E. Karnieli, and J. E. Pessin, “Cytochrome P-450 CYP2E1 knockout mice are protected against high-fat diet-induced obesity and insulin resistance,” American Journal of Physiology-Endocrinology and Metabolism, vol. 302, pp. E532–E539, 2012. View at: Publisher Site | Google Scholar
  82. P. Tommasini, A. Sestili, A. Guidarelli, and O. Cantoni, “Hydrogen peroxide generated at the level of mitochondria in response to peroxynitrite promotes U937 cell death via inhibition of the cytoprotective signalling mediated by cytosolic phospholipase A2,” Cell Death and Differentiation, vol. 11, pp. 974–984, 2004. View at: Publisher Site | Google Scholar
  83. V. Vanasco, P. Evelson, A. Boveris, and S. Alvarez, “In situ and real time muscle chemiluminescence determines singlet oxygen involvement in oxidative damage during endotoxemia,” Chemico-Biological Interactions, vol. 184, pp. 313–318, 2010. View at: Publisher Site | Google Scholar
  84. Y.-J. Choi, H.-S. Shin, H. S. Choi et al., “Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes,” Laboratory Investigation, vol. 94, pp. 1114–1125, 2014. View at: Publisher Site | Google Scholar
  85. N. A. Belikova, Y. A. Vladimirov, A. N. Osipov et al., “Peroxidase activity and structural transitions of cytochrome c bound to cardiolipin-containing membranes,” Biochemistry, vol. 45, pp. 4998–5009, 2006. View at: Publisher Site | Google Scholar
  86. S. Miyamoto, I. L. Nantes, P. A. Faria et al., “Cytochrome c-promoted cardiolipin oxidation generates singlet molecular oxygen,” Photochemical & Photobiological Sciences, vol. 11, pp. 1536–1546, 2012. View at: Publisher Site | Google Scholar
  87. Y. Kato, Y. Mori, Y. Makino et al., “Formation of Nε-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification,” Journal of Biological Chemistry, vol. 274, pp. 20406–20414, 1999. View at: Publisher Site | Google Scholar
  88. L. Trezl, G. Torok, G. Vasvari, J. Pipek, and L. Hullan, “Formation of burst of chemiluminescence, excited aldehydes, and singlet oxygen in model reactions and from carcinogenic compounds in rat liver S9 fractions,” Periodica Polytechnica Chemical Engineering, vol. 36, pp. 236–239, 1992. View at: Google Scholar
  89. F. Tokuda, Y. Sando, H. Matsui, and T. Yokoyama, “N epsilon-(hexanoyl) lysine, a new oxidative stress marker, is increased in metabolic syndrome, but not in obstructive sleep apnea,” American Journal of Medical Science, vol. 338, pp. 127–133, 2009. View at: Publisher Site | Google Scholar
  90. L. Trézl, L. Hullán, T. Szarvas, A. Csiba, and J. Pipek, “Analogies and differences in the excited reactions of formaldehyde and D-glucose,” Acta Biologica Hungarica, vol. 49, pp. 437–447, 1998. View at: Google Scholar
  91. K. Park, M. Gross, D.-H. Lee et al., “Oxidative stress and insulin resistance,” Diabetes Care, vol. 32, pp. 1302–1307, 2009. View at: Publisher Site | Google Scholar
  92. M. S. Linna, M. Ahotupa, K. Kukkonen-Harjula, M. Fogelholm, and T. J. Vasankari, “Co-existence of insulin resistance and high concentrations of circulating oxidized LDL lipids,” Annals of Medicine, vol. 47, pp. 394–398, 2015. View at: Publisher Site | Google Scholar
  93. J. Tanaka, L. Qiang, A. S. Banks et al., “Foxo1 links hyperglycemia to LDL oxidation and endothelial nitric oxide synthase dysfunction in vascular endothelial cells,” Diabetes, vol. 58, pp. 2344–2354, 2009. View at: Publisher Site | Google Scholar
  94. Y. Feng, Z. R. Cai, Y. Tang et al., “TLR4/NF-κB signaling pathway-mediated and oxLDL-induced up-regulation of LOX-1, MCP-1, and VCAM-1 expressions in human umbilical vein endothelial cells,” Genetics and Molecular Research, vol. 13, pp. 680–695, 2014. View at: Publisher Site | Google Scholar
  95. B. Scazzocchio, R. Varì, M. D'Archivio et al., “Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases,” Journal of Lipid Research, vol. 50, pp. 832–845, 2009. View at: Publisher Site | Google Scholar
  96. D. J. Kennedy, S. Kuchibhotla, K. M. Westfall, R. L. Silverstein, R. E. Morton, and M. Febbraio, “A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signaling,” Cardiovascular Research, vol. 89, pp. 604–613, 2011. View at: Publisher Site | Google Scholar
  97. B. Scazzochio, R. Vari, C. Filesi et al., “Cyanidin-3-O-β-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARγ activity in human omental adipocytes,” Diabetes, vol. 60, pp. 2234–2244, 2011. View at: Publisher Site | Google Scholar
  98. R. Ye and P. E. Scherer, “Adiponectin, driver or passenger on the road to insulin sensitivity?” Molecular Metabolism, vol. 2, pp. 133–141, 2013. View at: Publisher Site | Google Scholar
  99. J. B. Sedgwick, Y. S. Hwang, H. A. Gerbyshak, H. Kita, and W. W. Busse, “Oxidized low-density lipoprotein activates migration and degranulation of human granulocytes,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, pp. 702–709, 2003. View at: Publisher Site | Google Scholar
  100. P. Niethammer, C. Grabher, A. T. Look, and T. J. Mitchison, “A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish,” Nature, vol. 459, pp. 996–999, 2009. View at: Publisher Site | Google Scholar
  101. J. A. Chavez and S. A. Summers, “A ceramide-centric view of insulin resistance,” Cell Metabolism, vol. 15, pp. 585–594, 2012. View at: Publisher Site | Google Scholar
  102. S. Grether-Beck, A. Timmer, I. Felsner, H. Brenden, D. Brammertz, and J. Krutmann, “Ultraviolet A-induced signaling involves a ceramide-mediated autocrine loop leading to ceramide de novo synthesis,” Journal of Investigative Dermatology, vol. 125, pp. 545–553, 2005. View at: Publisher Site | Google Scholar
  103. L. Liao, Q. Zhou, Y. Song et al., “Ceramide mediates Ox-LDL-induced human vascular smooth muscle cell calcification via p38 mitogen-activated protein kinase signaling,” PLoS One, vol. 8, no. 12, article e82379, 2013. View at: Publisher Site | Google Scholar
  104. A. Özer, M. Bakacak, H. Kıran et al., “Increased oxidative stress is associated with insulin resistance and infertility in polycystic ovary syndrome,” Ginekologia Polska, vol. 2016, no. 87, pp. 733–738, 2016. View at: Publisher Site | Google Scholar
  105. S. Sakuma, M. Negoro, T. Kitamura, and Y. Fujimoto, “Xanthine oxidase-derived reactive oxygen species mediate 4-oxo-2-nonenal-induced hepatocyte cell death,” Toxicology and Applied Pharmacology, vol. 249, pp. 127–131, 2010. View at: Publisher Site | Google Scholar
  106. T. Shibata, Y. Shimozu, C. Wakita et al., “Lipid peroxidation modification of protein generates Nepsilon-(4-oxononanoyl)lysine as a pro-inflammatory ligand,” Journal of Biological Chemistry, vol. 286, pp. 19943–19957, 2011. View at: Publisher Site | Google Scholar
  107. K. H. Ingram, H. Hill, D. R. Moellering et al., “Skeletal muscle lipid peroxidation and insulin resistance in humans,” The Journal of Clinical Endocrinology & Metabolism, vol. 97, no. 7, pp. E1182–E1186, 2012. View at: Publisher Site | Google Scholar
  108. C. Schneider, N. A. Porter, and A. R. Brash, “Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation,” Journal of Biological Chemistry, vol. 283, pp. 15539–15543, 2008. View at: Publisher Site | Google Scholar
  109. A. N. Onyango and N. Baba, “New hypotheses on the pathways of formation of malondialdehyde and isofurans,” Free Radical Biology and Medicine, vol. 49, pp. 1594–1600, 2010. View at: Publisher Site | Google Scholar
  110. A. N. Onyango, “Small reactive carbonyl compounds as tissue lipid oxidation products; and the mechanisms of their formation thereby,” Chemistry and Physics of Lipids, vol. 165, pp. 777–786, 2012. View at: Publisher Site | Google Scholar
  111. M. Öhrvall, S. Tengblad, B. Ekstrand, A. Siegbahn, and B. Vessby, “Malondialdehyde concentration in plasma is inversely correlated to the proportion of linoleic acid in serum lipoprotein lipids,” Atherosclerosis, vol. 108, pp. 103–110, 1994. View at: Publisher Site | Google Scholar
  112. Y. Shimozu, K. Hirano, T. Shibata, N. Shibata, and K. Uchida, “4-Hydroperoxy-2-nonenal is not just an intermediate but a reactive molecule that covalently modifies proteins to generate unique intramolecular oxidation products,” Journal of Biological Chemistry, vol. 286, pp. 29313–29324, 2011. View at: Publisher Site | Google Scholar
  113. A. N. Grechkin, F. Brühlmann, L. S. Mukhtarova, Y. V. Gogolev, and M. Hamberg, “Hydroperoxide lyases (CYP74C and CYP74B) catalyze the homolytic isomerization of fatty acid hydroperoxides into hemiacetals,” Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1761, pp. 1419–1428, 2006. View at: Publisher Site | Google Scholar
  114. A. N. Onyango, “Formation of aldehydic phosphatidylcholines during the anaerobic decomposition of a phosphatidylcholine bearing the 9-hydroperoxide of linoleic acid,” BioMed Research International, vol. 2016, Article ID 8218439, 10 pages, 2016. View at: Publisher Site | Google Scholar
  115. A. D. Wentworth, B.-D. Song, J. Nieva, A. Shafton, T. Sangeetha, and P. Wentworth Jr, “The ratio of cholesterol 5,6 secosterols formed from ozone and singlet oxygen offers insight into the oxidation of cholesterol in vivo,” Chemical Communications, no. 21, pp. 3098–3100, 2009. View at: Publisher Site | Google Scholar
  116. Y. L. Lai, S. Tomono, N. Miyoshi, and H. Ohshima, “Inhibition of endothelial- and neuronal-type, but not inducible-type, nitric oxide synthase by the oxidized cholesterol metabolite secosterol aldehyde: implications for vascular and neurodegenerative diseases,” Journal of Clinical Biochemistry and Nutrition, vol. 50, pp. 84–89, 2011. View at: Publisher Site | Google Scholar
  117. S. Kashiwagi, D. N. Atochin, Q. Li et al., “eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity,” Biochemical and Biophysical Research Communications, vol. 431, pp. 284–290, 2013. View at: Publisher Site | Google Scholar
  118. N. Miyoshi, “Chemical alterations and regulations of biomolecules in lifestyle-related diseases,” Bioscience, Biotechnology and Biochemistry, vol. 80, pp. 1046–1053, 2016. View at: Publisher Site | Google Scholar
  119. P. Wentworth Jr., J. Nieva, C. Takeuchi et al., “Evidence for ozone formation in human atherosclerotic arteries,” Science, vol. 302, pp. 1053–1056, 2003. View at: Publisher Site | Google Scholar
  120. S. Tomono, N. Miyoshi, M. Ito, T. Higashi, and H. Ohshima, “A highly sensitive LC–ESI-MS/MS method for the quantification of cholesterol ozonolysis products secosterol-A and secosterol-B after derivatization with 2-hydrazino-1-methylpyridine,” Journal of Chromatography B, vol. 879, pp. 2802–2808, 2011. View at: Publisher Site | Google Scholar
  121. A. N. Onyango, “Alternatives to the ‘water oxidation pathway’ of biological ozone formation,” Journal of Chemical Biology, vol. 9, pp. 1–8, 2016. View at: Publisher Site | Google Scholar
  122. S. Tomono, N. Miyoshi, K. Sato, Y. Ohba, and H. Ohshima, “Formation of cholesterol ozonolysis products through an ozone-free mechanism mediated by the myeloperoxidase-H2O2-chloride system,” Biochemical and Biophysical Research Communications, vol. 383, pp. 222–227, 2009. View at: Publisher Site | Google Scholar
  123. T. C. Genaro-Mattos, R. F. Queiroz, D. Cunha et al., “Cytochrome c reacts with cholesterol hydroperoxides to produce lipid-and protein-derived radicals,” Biochemistry, vol. 54, pp. 2841–2850, 2015. View at: Publisher Site | Google Scholar
  124. R. C. Murphy and K. M. Johnson, “Cholesterol, reactive oxygen species, and the formation of biologically active mediators,” Journal of Biological Chemistry, vol. 283, pp. 15521–15525, 2008. View at: Publisher Site | Google Scholar

Copyright © 2017 Arnold N. Onyango. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.